Walleye Capital’s HOOKIPA Pharma HOOK Stock Holding History

Walleye Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-114,504	Closed	-$1.01M	–	5055
2023 Q2	$1.01M	Buy	+114,504	New	+$1.27M	﹤0.01%	1849
2022 Q2	–	Sell	-4,485	Closed	-$102K	–	2518
2022 Q1	$102K	Sell	4,485 -14,030	-76%	-$251K	﹤0.01%	1740
2021 Q4	$431K	Buy	18,515 +8,216	+80%	+$330K	0.01%	1071
2021 Q3	$607	Buy	+10,299	New	+$747K	0.02%	697

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's HOOK Position: Q3 2023 in Review

Walleye Capital sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 114,504 shares — an estimated $1.01M sold.

Walleye Capital first reported a position in HOOK in Q3 2021 and held it in 4 quarters. The position peaked at $1.01M in Q2 2023. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

Walleye Capital reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 114,504 HOOKIPA Pharma shares in Q3 2023, an estimated $1.01M.
Walleye Capital first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 4 quarters.
Walleye Capital's HOOKIPA Pharma position peaked at $1.01M in Q2 2023.
44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.